INTRODUCTION
Monoclonal proteins with antibody-like activity toward endogenous serum protein, i.e. rheumatoid factor, have been described and are thought to be the product of aberrant clones of cells that have their representation
Received for publication 11 January 1974 and in revised form 18 February 1974. in a normal cell population (1) (2) (3) . For example, the sera of elderly people frequently contain rheumatoid factor without associated disease (4) , and agglutinators of red blood cells sensitized with pepsin and papaindigested IgG, have also been recognized in normal sera (5) (6) (7) . These are thought to represent an antibody response to antigen-antibody complexes or to gamma globulin altered during normal metabolic processes.
In a previous communication (8) we reported a monoclonal IgM protein (L'ec) with antibody-like activity toward native and denatured albumin and suggested that this protein might be representative of an antibody which functions in some unknown manner in the normal metabolism of albumin. The present study was undertaken to determine whether an albumin antibody could be demonstrated in normal or nonmyeloma sera. Inasmuch as albumin accounts for over 50% of the protein present in normal human serum, the demonstration of this antibody might be obscured by a large antigen excess. A similar proposal has been offered for "hidden" rheumatoid factors which are saturated at the antigen-binding site by normal IgG (9) . Therefore, the ideal sera to search for albumin antibodies would be those in which the serum albumin is markedly diminished, as is frequently found in Laennec's cirrhosis. This report describes the presence in cirrhotic sera of antibody-like activity, predominantly in the IgA class, to aggregated albumin.
METHODS
Sera. The sera used in this study were Hemagglutination. Hemagglutination was carried out by the technique of Boyden (12) with the use of tanned sheep red blood cells (SRBC) coated with heat-aggregated albumin. The titers are expressed as the reciprocal of the highest dilution demonstrating 3 or 4+ hemagglutination.
Facilitation of hemagglutination (13) 
RESULTS
Fresh whole cirrhotic sera were examined by hemagglutination using tanned SRBC coated with aggregated albumin. As shown in Table I , 7 of 18 cirrhotic sera had positive hemagglutination titers ranging from 16 to 256. The controls, consisting of 5 normal human sera, 15 macroglobulinemic sera, 20 IgA myeloma sera, 2 cord sera, and 1 hypogammaglobulinemic serum were all negative. The sera with positive hemagglutination titers all had marked hypergammaglobulinemia and hypoalbuminemia. We have tested by hemagglutination 13 patients with hypergammaglobulinemia and connective tissue disease but with no associated liver disease and these sera were all negative. In addition, a small number of sera from patients with other types of liver disease, i.e. infectious mononucleosis (two), acute viral hepatitis (four), and chronic biliary cirrhosis (three), were tested and found to be negative for antialbumin antibodies. Antibodies to Albumin To identify the immunoglobulin (s) responsible for the hemagglutinating activity, pool I was subjected to affinity chromatography utilizing an aggregated albumin immunoadsorbent as described above. The acid eluates of three pool I preparations derived from different cirrhotic sera contained only IgA by gel diffusion analysis using specific antisera to all immunoglobulin classes. Controls, consisting of three different isolated monoclonal IgA preparations, two monoclonal IgM, one monoclonal IgG protein, as well as pool II, were each chromatographed over the same column. These preparations showed no significant adsorption to the column. This demonstrated the specificity of the cirrhotic IgA for aggregated albumin. As a positive control, the previously mentioned monoclonal IgM protein with antibody activity toward albumin was also subjected to affinity chromatography. In this case, all of the protein was adsorbed to the column.
Cirrhotic IgA obtained by acid elution from an aggregated albumin immunoadsorbent was radiolabeled with 'I and digested with pepsin as described in the Methods section. The labeled Faba was then analyzed for its ability to complex with albumin using the aggregated albumin-immunoadsorbent column. The results of a typical experiment are shown in Table III ). The specificity of cirrhotic IgA for altered albumin could also be demonstrated utilizing hemagglutination of SRBC coated with aggregated albumin. In these experiments facilitating antisera were used to enhance hemagglutination as shown in Table IV . The cirrhotic IgA obtained by acid elution from the aggregated albumin immunoadsorbent had only weak direct agglutinating activity at 200 Mg/ml. However, when an antiIgA antiserum was used to facilitate, the titers increased to greater than 2,000. Similarly, an anti-Lchain antiserum increased the hemagglutination titer of the cirrhotic IgA to 1,024. Appropriate controls of coated and uncoated cells with specific antisera and uncoated cells plus the acid eluate plus specific antisera were all negative. Two IgA and two IgM monoclonal proteins were also used as controls at the same concentrations as the acid eluates and there was no facilitation of hemagglutination. The cirrhotic Faba (300 Lg/ml), obtained by acid elution from the aggregated albumin immunoadsorbent column, was shown to be specifically bound to albumincoated SRBC by demonstrating a titer of 512 when an anti-L-chain antiserum was employed to facilitate hemagglutination. Control Fab from two IgA and two IgM monoclonal proteins at the same protein concentrations were negative, as were the controls of coated and uncoated cells with specific antisera and uncoated cells plus the acid eluate plus specific antisera.
The presence of secretory component was investigated in cirrhotic sera and isolated cirrhotic IgA and we were unable to demonstrate it in any of these preparations.
Although this was a retrospective study, some information can be gleaned from the clinical data. The seven patients demonstrating significant antibody titers tended to have more severe manifestations of chronic liver disease, i.e., jaundice, ascites, and edema. In this regard all of the patients with both antialbumin antibody titers and severe liver disease were shown to have marked hypergammaglobulinemia and hypoalbuminemia on protein electrophoresis. The 11 patients with negative titers had a mean albumin concentration of 3.3 g/100 ml (normal range 3.0-4.0 g/100 ml) (patient range 2.8-3.9 g/100 ml) with a mean gamma globulin concentration of 2.2 g/100 ml (normal range 0.94-2.1 g/100 ml) (patient range 1.9-2.6 g/100 ml).
The seven patients with positive titers had a mean albumin concentration of 2.0 g/100 ml and a mean gamma globulin concentration of 4.2 g/100 ml. In spite of these overall relationships, there was no direct correlation between the height of the antibody titer and the degree of hypoalbuminemia and/or hypergammaglobulinemia.
DISCUSSION
In this study, antibody-like activity against altered albumin was demonstrated in cirrhotic sera. All positive sera had a marked polyclonal elevation of immunoglobulins and diminished albumin. Chromatography of positive sera on Sephadex G-200 demonstrated that the hemagglutinating activity for aggregated albumin was restricted to the void volume pool. By selectively depleting this pool of immunoglobulins, employing an anti-L-chain immunoadsorbent column, it was established that immunoglobulins were responsible for the activity. Utilizing an aggregated albumin immunoadsorbent column it was shown that only IgA was bound to the column and this could be recovered by acid elution. The IgA isolated by this method and the Faba derived from it by pepsin proteolysis, could be shown by several techniques (facilitated hemagglutination and the adsorbence of [ ¶I]Faba to aggregated albumin columns) to complex with aggregated albumin.
No attempt was made in this study to determine whether the cirrhotic IgA complexed with native as opposed to altered albumin. However, the occurrence of positive titers in whole cirrhotic sera containing aboul 3 g/100 ml of albumin suggested that inhibition by native monomer (4S) albumin occurs only at high albumin concentrations if at all. This was also found in a previous study (8) , where concentrations of monomer albumin above 50 mg/ml were necessary to inhibit hemagglutination of SRBC coated with aggre-gated albumin by a monoclonal IgM protein having antibody-like activity toward albumin.
Although the cirrhotic Faba was shown to be selectively removed by the aggregated albumin immunoadsorbent column, only 43 and 33% were absorbed from the two preparations on the first passage over the column. The observation that significantly less than 100% adsorption occurred may be explained by some loss in activity caused by the acid elution, or by iodination of the original IgA. Also, since the pepsin digest of the labeled IgA was not fractionated after digestion, there may have been present nondialyzable labeled fragments derived from the Fc. After recovering the adsorbed Faba, a second passage over the same affinity column resulted in nearly 100% adsorption as shown in Table III .
The reason for the antibody response to altered albumin and its selective occurrence in the IgA class is unknown. Since a significant portion of serum IgA may be synthesized by plasma cells in the lamina propria of the small intestine (14) , it is possible that the albumin reactive IgA found in cirrhotic sera originates in the gastrointestinal tract. In this regard, it has been clearly established that albumin is present on the mucosal surface of the intestinal tract and the gut is thought to be a major site of albumin catabolism in man (15) (16) (17) . In addition, there are changes in bacterial flora and enzyme content of the gastrointestinal fluid in cirrhosis (18) that may lead to excessive and/or an altered albumin catabolism. Thus, albumin altered in the course of normal or abnormal (cirrhotic) metabolism may serve as a source of local gastrointestinal immunization, producing antibodies limited to the IgA class. This is consistent with the restriction of albumin reactive IgA to the Sephadex void volume of cirrhotic sera. Gut IgA is synthesized predominantly as a dimer and would chromatograph close to the void volume. An additional factor in determining chromatographic position may be the presence of complexes of IgA and monomer albumin. The albumin antibodies could also arise at least in part, from immunocytes located in the liver. Hadziyannis, Feizi, Scheuer, and Sherlock (19) have reported that IgA-containing cells were the predominant cell type in alcoholic cirrhosis and most other liver diseases with the exception of primary biliary cirrhosis in which the majority of cells were IgM. Moreover, these workers found that when large numbers of cells of a certain immunoglobulin type were present in the liver, the respective serum immunoglobulin level was almost always elevated.
Another possibility, admittedly speculative, is that alcohol itself not only causes toxic injury to the liver resulting in decreased albumin synthesis but also structurally alters the final product. Albumin could also be altered locally in the gastrointestinal tract by continuing high concentrations of alcohol. The altered albumin might then serve as the immunizing agent either in the liver and/or gastrointestinal tract resulting in an antibody that reacts with heat-aggregated albumin and cross-reacts with normal serum albumin although the latter point was not investigated in this study.
It is interesting to speculate on the possible biological effects of the antialbumin antibodies. The antibody could alter the synthesis and/or catabolism of albumin. There is precedence for an effect of antibody on both synthesis (20) and catabolism (21) of proteins. It is also conceivable that immune complexes containing altered albumin or the development of delayed hypersensitivity to albumin might perpetuate liver damage initiated by alcohol. The question of whether immune complexes of IgA and albumin and/or whether cellular immunity to albumin is present in cirrhotics is currently being investigated.
The coexistence of severe liver disease with hypergammaglobulinemia and hypoalbuminemia could be positively correlated with the presence of antibodies to aggregated human albumin. Although this might support the argument of antibodies having a role in the pathogenesis of chronic liver disease, it is also possible that this is a secondary phenomenon and that patients with more severe liver disease tend to develop these antibodies late in their clinical course and they have little significance in the pathogenesis of the disease. A prospective study is needed to clarify this point. Although we were unable to demonstrate albumin antibodies in nine patients with liver diseases other than alcoholic cirrhosis, no definite conclusions concerning specificity of these antibodies for Laennec's cirrhosis can be drawn. A larger study of various liver disease sera, including chronic active hepatitis, is needed to answer this question.
